Global Genotyping Assay Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Genotyping Assay Market Research Report 2024
Genotyping assays aim to discriminate between sequences, rather than measure the level of a particular DNA sequence.
According to MRAResearch’s new survey, global Genotyping Assay market is projected to reach US$ 76560 million in 2033, increasing from US$ 21880 million in 2022, with the CAGR of 19.3% during the period of 2023 to 2033.
North America is expected to account for the largest market size in the global genotyping assay market during the forecast period, followed by the European region. Increasing adoption of technologically advanced genotyping products, high healthcare expenditure, advanced healthcare infrastructure, highly developed healthcare systems in the U.S. and Canada, numerous genotyping-based R&D projects, and a large number of leading genotyping Presence of manufacturers in the region, along with rising demand for genotyping products from pharmaceutical companies and rising investments by government agencies, are factors that account for a large share of the North America genotyping assay market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Genotyping Assay market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Illumina
Thermo Fisher Scientific
Roche
Qiagen N.V.
Agilent
Fluidigm
Genewiz
Integrated Dna Technologies
Perkinelmer
Bio-Rad Laboratories
Eurofins Scientific
Segment by Type
PCR
Sequencing
Microarray
Others
Pharmacogenomics
Diagnostic Research
Animal Genetics
Agricultural Biotechnology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Genotyping Assay report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Genotyping Assay market is projected to reach US$ 76560 million in 2033, increasing from US$ 21880 million in 2022, with the CAGR of 19.3% during the period of 2023 to 2033.
North America is expected to account for the largest market size in the global genotyping assay market during the forecast period, followed by the European region. Increasing adoption of technologically advanced genotyping products, high healthcare expenditure, advanced healthcare infrastructure, highly developed healthcare systems in the U.S. and Canada, numerous genotyping-based R&D projects, and a large number of leading genotyping Presence of manufacturers in the region, along with rising demand for genotyping products from pharmaceutical companies and rising investments by government agencies, are factors that account for a large share of the North America genotyping assay market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Genotyping Assay market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Illumina
Thermo Fisher Scientific
Roche
Qiagen N.V.
Agilent
Fluidigm
Genewiz
Integrated Dna Technologies
Perkinelmer
Bio-Rad Laboratories
Eurofins Scientific
Segment by Type
PCR
Sequencing
Microarray
Others
Segment by Application
Pharmacogenomics
Diagnostic Research
Animal Genetics
Agricultural Biotechnology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Genotyping Assay report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source